Study uncovers SNHG10's role in tumor progression and drug resistance in pancreatic cancer, suggesting new treatment targets.
Study uncovers how SNHG10 drives tumour progression and chemotherapy resistance, offering a potential new therapeutic target. Study uncovers how SNHG10 drives tumour progression and chemotherapy resistance, offering a potential new therapeutic target.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: